series-c-plus
Stage
1
Investors
About
Jounce Therapeutics is a clinical-stage biopharmaceutical company developing immunotherapies for cancer, focusing on biologics that modulate the tumor microenvironment and restore anti-tumor T cell function.
Explore Jounce Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.